Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,398 | 79 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $167.10 | 9 | $0 (2021) |
| GlaxoSmithKline, LLC. | $160.23 | 9 | $0 (2021) |
| Madrigal Pharmaceuticals | $150.00 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $148.31 | 9 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $127.11 | 8 | $0 (2020) |
| Novo Nordisk Inc | $106.46 | 6 | $0 (2021) |
| PFIZER INC. | $101.44 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $95.52 | 7 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.33 | 4 | $0 (2021) |
| SANOFI PASTEUR INC. | $57.08 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150.00 | 1 | Madrigal Pharmaceuticals ($150.00) |
| 2021 | $150.93 | 8 | Novo Nordisk Inc ($63.77) |
| 2020 | $171.30 | 10 | GlaxoSmithKline, LLC. ($45.64) |
| 2019 | $266.76 | 18 | Astellas Pharma US Inc ($74.17) |
| 2018 | $359.91 | 22 | Janssen Pharmaceuticals, Inc ($83.94) |
| 2017 | $299.43 | 20 | PFIZER INC. ($64.21) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/15/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Obesity | ||||||
| 09/30/2021 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: VACCINE | ||||||
| 08/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 07/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: UROLOGY | ||||||
| 05/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Diabetes | ||||||
| 05/13/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: VACCINES | ||||||
| 07/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: VACCINES | ||||||
| 02/25/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Endocrinology | ||||||
| 02/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiovascular | ||||||
| 02/04/2020 | SANOFI PASTEUR INC. | MENACTRA (Biological), ADACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Vaccines | ||||||
| 01/17/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological), TOUJEO | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Endocrinology | ||||||
| 01/06/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: UROLOGY | ||||||
| 01/03/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Cardiovascular | ||||||
| 11/07/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: UROLOGY | ||||||
| 11/04/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: VACCINES | ||||||
| 10/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 08/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: UROLOGY | ||||||
| 06/18/2019 | SANOFI PASTEUR INC. | ADACEL (Drug), FLUZONE HIGH-DOSE, FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 401 | 485 | $73,396 | $22,762 |
| 2022 | 8 | 388 | 474 | $70,262 | $21,892 |
| 2021 | 7 | 441 | 552 | $74,019 | $42,500 |
| 2020 | 9 | 377 | 442 | $58,410 | $27,710 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 180 | $32,400 | $8,840 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 134 | $16,348 | $6,376 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $15,996 | $3,987 | 24.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 21 | $2,562 | $1,135 | 44.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $3,360 | $1,013 | 30.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 16 | $1,200 | $701.84 | 58.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $680.00 | $533.29 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $850.00 | $176.40 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 192 | $34,560 | $9,402 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 104 | $12,688 | $5,142 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 94 | 94 | $17,484 | $4,554 | 26.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 25 | $3,050 | $1,716 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $680.00 | $520.37 | 76.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 14 | 14 | $1,050 | $416.15 | 39.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 15 | $750.00 | $141.84 | 18.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 13 | $0.13 | $0.13 | 100.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 129 | 211 | $37,980 | $19,381 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 100 | 100 | $18,600 | $13,794 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 92 | 119 | $14,518 | $8,186 | 56.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 53 | 53 | $2,120 | $939.59 | 44.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 16 | $800.00 | $198.72 | 24.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 41 | 41 | $0.41 | $0.41 | 100.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 12 | 12 | $0.12 | $0.12 | 100.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 101 | 101 | $18,786 | $12,093 | 64.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 146 | $26,280 | $10,643 | 40.5% |
About Dr. Sarah Riedo, M.D
Dr. Sarah Riedo, M.D is a Internal Medicine healthcare provider based in Bristol, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2012. The National Provider Identifier (NPI) number assigned to this provider is 1467712349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Riedo, M.D has received a total of $1,398 in payments from pharmaceutical and medical device companies, with $150.00 received in 2024. These payments were reported across 79 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,398).
As a Medicare-enrolled provider, Riedo has provided services to 1,607 Medicare beneficiaries, totaling 1,953 services with total Medicare billing of $114,864. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bristol, RI
- Active Since 05/24/2012
- Last Updated 06/18/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467712349
Products in Payments
- REZDIFFRA (Drug) $150.00
- XARELTO (Drug) $148.31
- MYRBETRIQ (Drug) $128.29
- ELIQUIS (Drug) $127.11
- FARXIGA (Drug) $95.52
- CHANTIX (Drug) $65.28
- SHINGRIX (Biological) $50.48
- TRELEGY ELLIPTA (Drug) $48.36
- Ozempic (Drug) $45.58
- Vascepa (Drug) $41.10
- Myrbetriq (Drug) $38.81
- STIOLTO (Drug) $37.32
- TRULICITY (Drug) $34.46
- BREO (Drug) $31.69
- NO PRODUCT DISCUSSED (Drug) $29.61
- Victoza (Drug) $28.56
- SOLIQUA 100/33 (Biological) $27.86
- PREVNAR - 13 (Biological) $23.72
- OFEV (Drug) $23.61
- PNEUMOVAX 23 (Biological) $22.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bristol
Dr. Bernard Grunstra, Md, MD
Internal Medicine — Payments: $36,895
Charles Villoch, Md, MD
Internal Medicine — Payments: $25,124
Dr. Joseph Foley, M.d, M.D
Internal Medicine — Payments: $21,160
Dr. Nathan Gargus, M.d, M.D
Internal Medicine — Payments: $17,677
Rick Whiles, Md, MD
Internal Medicine — Payments: $17,415
Dr. Donald Quinn, Md, MD
Internal Medicine — Payments: $17,216